Browsing: obesity

The Dangers of Infant Screen Time: A Closer Look at Its Impact on Infant Neurodevelopment

By 1
A Singapore study using electroencephalography showed that infants who spent more time on screens had increased electrocortical activity and worse executive functions later in life, such as memory, attention, and inhibition, than those who had less screen exposure. The researchers warned that screen time in early life might affect children’s learning and behaviour.

Log In or Register as a healthcare professional to read the full article.

Kimchi Consumption Linked to Lower Obesity: Study

By 0

The study utilised data from 115,726 participants enrolled in the Health Examinees (HEXA) study. The study is a component of the larger Korean Genome and Epidemiology Study. It is aimed at exploring the risk factors for chronic diseases among adults over 40 in Korea. Researchers assessed the participants’ dietary intake through a food frequency questionnaire, including their consumption of various types of kimchi. They analysed the relationship between kimchi intake, body mass index (BMI), and waist circumference.

Filipino Physicians Warn Rise Of More Dangerous Strain of Fatty Liver Disease

By 0

As the world shifts its focus from the immediate threat of the COVID-19 pandemic, another health concern, often silent but equally impactful, is gaining prominence. Non-alcoholic Fatty Liver Disease (NAFLD), recognised as the “silent epidemic,” has emerged as a significant global health issue, affecting an estimated 38% of the world’s population.

MIT Scientists Develop Vibrating Capsule To Treat Obesity

By 0

The vibrating capsule, likened to the feeling of drinking a glass full of water before eating, targets the brain’s perception of satiety. When ingested 20 minutes prior to a meal, it stimulates mechanoreceptors, which in turn signal the brain via the vagus cranial nerve. This signal initiates the production of hormones such as insulin, GLP-1, C-peptide, and PYY, reducing hunger and enhancing the digestion process. In animal models, this mechanism resulted in a reduction of food consumption by about 40%.

Not just weight loss – Semaglutide and Cardiovascular Benefits

By 0
With the emergence and increasing popularity of glucagon-like peptide 1 (GLP-1) agonists for the treatment of obesity in recent years, it might be worth investigating if these agents are able to reduce the cardiovascular risks associated with overweight and obesity, especially since they have been shown to reduce risk of major adverse cardiovascular events in patients with type 2 diabetes who are at high cardiovascular risk.

Log In or Register as a healthcare professional to read the full article.